OS Therapies Inc. Files 8-K: Material Agreement, Equity Sales
Ticker: OSTX · Form: 8-K · Filed: Jul 14, 2025 · CIK: 1795091
| Field | Detail |
|---|---|
| Company | Os Therapies Inc (OSTX) |
| Form Type | 8-K |
| Filed Date | Jul 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, equity-sale, 8-k
TL;DR
OS Therapies Inc. signed a big deal and sold stock, filing an 8-K on 7/14/25.
AI Summary
On July 11, 2025, OS Therapies Inc. entered into a Material Definitive Agreement, the details of which are not fully disclosed in this filing. The company also reported on unregistered sales of equity securities and other events. The filing was made on July 14, 2025.
Why It Matters
This 8-K filing indicates significant corporate activity for OS Therapies Inc., including a material definitive agreement and unregistered equity sales, which could impact its financial structure and future operations.
Risk Assessment
Risk Level: medium — The filing mentions unregistered sales of equity securities, which can sometimes indicate financial needs or dilution concerns for existing shareholders.
Key Players & Entities
- OS Therapies Inc. (company) — Registrant
- July 11, 2025 (date) — Date of earliest event reported
- July 14, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- 20850 (zip_code) — Business address zip code
- 410-297-7793 (phone_number) — Business phone number
FAQ
What is the nature of the Material Definitive Agreement entered into by OS Therapies Inc. on July 11, 2025?
The specific details of the Material Definitive Agreement are not disclosed in this 8-K filing, which only reports its entry.
What were the terms of the unregistered sales of equity securities mentioned in the filing?
The filing acknowledges unregistered sales of equity securities but does not provide specific terms, amounts, or pricing details.
When did OS Therapies Inc. file this Current Report on Form 8-K?
OS Therapies Inc. filed this Current Report on Form 8-K on July 14, 2025.
What is the principal executive office address for OS Therapies Inc.?
The principal executive office address for OS Therapies Inc. is 15825 Shady Grove Road, Suite 135, Rockville, MD 20850.
What is the SIC code for OS Therapies Inc.?
The Standard Industrial Classification (SIC) code for OS Therapies Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 14, 2025 regarding OS Therapies Inc (OSTX).